Table 1.
Baseline characteristics
| Patient characteristics | All patients (n=62) | Intervention group (n=30) | Non-intervention group (n=32) |
|---|---|---|---|
|
| |||
| Gender: male/female | 14/48 | 8/22 | 6/26 |
| Age (years; mean ± SD) | 54.5±11.6 | 52.7±12.9 | 54.3±9.8 |
| Cancer type, n (%) | |||
| Gastrointestinal | 29 (47%) | 17 (59%) | 12 (41%) |
| Breast | 31 (50%) | 11 (37%) | 20 (63%) |
| Lung | 2 (3%) | 2 (7%) | 0 (0%) |
| Treatment, n (%) | |||
| Single agent of taxane, platinum, anthracycline, or fluoropyrimidin | 12 (19%) | 6 (20%) | 6 (19%) |
| Combination chemotherapy combination with platinum | 50 (81%) 22 (35%) |
23 (77%) 15 (50%) |
27 (84%) 7 (22%) |